Gemphire Therapeutics Profile

9.48
USD 0.46  4.63%
8.95Last Month High 10.38 
9.14Trading Day  High 9.94 

Gemphire Therapeutics Risk Profiles

Key Fundamentals

Gemphire Therapeutics Against Markets

Gemphire Therapeutics Inc., a clinicalstage biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of dyslipidemia cardiovascular disease. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
NameGemphire Therapeutics Inc
Macroaxis Advice
InstrumentUSA Stock Stocks Directory
LocationMICHIGAN, U.S.A
Business AddressNorthville, MI
ExchangeBATS Exchange
CUSIP36870A108
IndustryPharmaceutical Products
BenchmarkDOW
Websitewww.gemphire.com
Contact Number248 681 9815
CurrencyUSD - US Dollar

Directors

Gemphire Therapeutics Corporate Directors
Kenneth Kousky Independent Director
Andrew Sassine Independent Director, MBA
Pedro Lichtinger Independent Director, MBA

Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas